530080-19-4

Basic information

• Product Name: (4-BROMOPHENYL)(2,2,2-TRIFLUOROETHYL)SULFANE
• Synonyms: (4-BROMOPHENYL)(2,2,2-TRIFLUOROETHYL)SULFANE;1-Bromo-4-(2,2,2-trifluoroethylsulfanyl)benzene
• CAS NO: 530080-19-4
• Molecular Formula: C₈H₆BrF₃S
• Molecular Weight: 271.11
• Mol File: 530080-19-4.mol
• Article Data: 4

Chemical Properties

• Appearance: /
• CAS DataBase Reference: (4-BROMOPHENYL)(2,2,2-TRIFLUOROETHYL)SULFANE(CAS DataBase Reference)
• NIST Chemistry Reference: (4-BROMOPHENYL)(2,2,2-TRIFLUOROETHYL)SULFANE(530080-19-4)
• EPA Substance Registry System: (4-BROMOPHENYL)(2,2,2-TRIFLUOROETHYL)SULFANE(530080-19-4)

Safety Data

• Hazardous Substances Data: 530080-19-4(Hazardous Substances Data)

Upstream product

• 106-53-6 para-bromobenzenethiol 
• 6334-55-0 allyl (4-bromophenyl)sulfide 
• 373-88-6 2,2,2-trifluroethylamine hydrochloride 
• 433-06-7 2,2,2-Trifluoroethyl p-toluenesulfonate 
• 371-67-5 2,2,2-trifluorodiazoethane 
• 421-06-7 2-bromo-1,1,1-trifluoroethane 

Downstream Products

• 648905-23-1 1-bromo-4-(2,2,2-trifluoro-ethanesulfonyl)-benzene 

Relevant articles and documents

Hemin Catalyzed Dealkylative Intercepted [2, 3]-Sigmatropic Rearrangement Reactions of Sulfonium Ylides with 2, 2, 2-Trifluorodiazoethane

A dealkylative intercepted [2, 3]-sigmatropic rearrangement reaction of allylic sulfides with 2, 2, 2-trifluorodiazoethane (CF3CHN2) is reported, the commercially available and biocompatible catalyst hemin was found to efficiently catalyze this transformation across a diverse set of allylic sulfides with in situ generated CF3CHN2, providing excellent yields (up to 99%) under mild condition without inert gas protection. In addition, CF3CHN2 exhibited unique reactivity toward this process compared with other frequently used diazo reagents. This work expands the range of carbene-mediated transformations catalyzed by hemin and introduces a concise and general strategy for exploiting new possibility of reactions concerning organosulfides. (Figure presented.).

OXAZOLIDINONE HYDROXAMIC ACID COMPOUNDS FOR THE TREATMENT OF BACTERIAL INFECTIONS

This invention pertains generally to treating bacterial infections using organic compounds of Formula I. In certain aspects, the invention pertains to treating infections caused by Gram-negative bacteria. (I) wherein X, Y, R1, R2, R3, R4 and R5 and defined herein.